A fourth dose of the vaccine will be needed to help fend off the next wave of COVID-19 — says Pfizer CEO Albert Bourla. He also announced that the company is working on a vaccine that would protect against all variants of COVID-19 for a year.
Pfizer CEO Albert Bourla on Sunday 13 March in an interview with CBS said that the adoption of the third dose of the vaccine against COVID-19 it is an effective protection that allows to prevent hospitalization and deaths. However, the third dose is not a good protection against the infection itself and does not last long against the Omicron. That’s why he needed a fourth dose for now, he said.
- Fourth dose for everyone? Clear position of the European Medicines Agency
Currently, anyone 12 years of age and older who received a second dose of Pfizer vaccine at least five months ago can receive a third dose. Some moderately or severely immunocompromised people who have received three doses of the vaccine may also receive a fourth dose.
- Who in Poland can get the fourth dose? The ministry made recommendations
A vaccine for all variants?
Albert Bourla also added: “Many variants are coming and Omikron was the first to skillfully avoid the immune protection we provide” — he said in an interview with CBS. Additionally, Pfizer and Moderna are developing a vaccine to target only the Omikron variant.
- Every eighth coronavirus case leads to a long covid
Bourla also said Pfizer wants to create a vaccine that will protect against Omicron and all other variants of the SARS-CoV-2 virus. The preparation would provide immunity to COVID-19 throughout the year. According to Bourla, it would allow a return to life from before the pandemic.
Have you been infected with COVID-19 and are worried about the side effects? Check your health by completing a comprehensive research package for convalescents.
See also:
- Has Israel beaten the coronavirus? “They were delighted with the success and announced the end of the pandemic”
- He had COVID-549 for 19 days. Finally he came home
- Blood group can influence the critical course of COVID-19. New arrangements